"Alcobra ADHD management team is sitting on the results as RIGHT NOW and writing up the press release...probably tickling as right now." " the downside is now limited after SHORTS attacked ADHD to pushed it down -38%. With a positive data, SHORTS will be toasted & BBQ too!" " A key bullet point from research: essentially every drug within the ADHD market that has passed phase2 studies has went on to be APPROVED!" " and furthermore company has already stated 1 goal is to sell itself to a larger pharmaceutical company during an interview in 2013." Now Looking to the high side...
ADHD ....if results not out tomorrow morning, probably won't see them at least until Monday. Friday morning Yom Kippur begins for many . Company likely closed. October 3-4, 2014 - Yom Kippur being a National holiday in Israel and for many in America.
Waiting for close or news ... I was just thinking as little as 2 weeks ago, shorts only controlled 6-7% of the ADHD stock. Than they came out of the woodwork and now I would say 15-20% or more have it. I hate that the SEC let's investors bet against success, not just here but across the board. When you go to Vegas you always for the most part bet against the house, but that is sanctioned gambling. Is the market now just sanctioned gambling. No one want's a product to get to market, so it seems. Betting against anyone else's success seems to be the thing to do on Wall Street. We all have some greed, but what is going on now is just way beyond some greed. If you want any success now to beat the shorts you have to get in at IPO or lower, lower than they find their positions. I realize they are my friends and neighbors, but I still loath they way they celebrate someone else's loss. Many hold their position and never own it or have paid for it, supposedly they have to cover if called, but never hear much about that. I'm usually long and have mixed success, but I see more and more shorts entering the market as if it is the only way to bet. So now my contemplation is exiting the market all together and maybe that is what will happen after I close this position in ADHD .. Win or Lose. Okay, I'm done, killed a few minutes.
Looks like buyers may have dried up, only a few sellers here and their. We are in a ubiquitous place at the moment. It's hard to see positive after so much negative. Those that write the negative articles are always short positioned and garner lot's of attention, but they are often wrong, but most feed on fear and that is who they appeal too. If you follow and bow to your fear, you will lose for sure.
Back in @ $13.05 hope that is the bottom, it's the year new low. It's going to be a long and painful wait for news, seems every minute now get's longer and longer. I remain optimistic, although I just saw I did not but at bottom ... now $12.90
Interesting story, but I don't think ADHD is that. I might if they were located in the Bahamas or Belize, not sure punishment would be lenient in Israel for such scams, but who really knows. Anything is possible if you want it to be.
I did I bought at ARNA at 3.47 and sold at 10.45 only had 2K in shares. Recently bought back 5K ARNA at $3.87. Plan on Holding long now. I've been in and out of ADHD the past few days down about 8K. Still looking at a reentry, trying to time it at the bottom, to recoup as much as possible, if not all. We are at 1 year lows right now. Probably an opening at 12.50 - 13.00. I believe most failure priced already when you figure 2 more trials are still outstanding, Fragile X and children A. I think everyone that is bailing out is now gone. Price will stay in narrow band until news, It could still go down, but I think not nearly as much as it could go up. That's my take, probably as good as anyone's. I'm going to retry my entry at 12.95 - 13.10 and hold for some news
The reason I ask is because ADHD is setting up exactly the same as ARNA did. The Street and AF were bad mouthing and supporting the short position, because they said Belviq could never be approved. The price tumbled just before FDA, than FDA approval and it went straight from around $3.00 to $11.00 before falling back to $8.00 for awhile. Is it possible we will see a repeat here, not with FDA news, but with P3 announcement? Positive news will create incredible havoc. Already pretty much set for negative news. Their seem to be an awful lot of short experts on ADHD just as their were with Diet pills, but we all know what happened with Belviq, just watch TV
It stung a lot of investors, including me for 8K .. now looking for reentry point. It will recover to some level above on news. Actually, likely to be a buying frenzy, how high, that's the question? What is the best re-entry point?
Stockpush ... If I had to guess and that is the only thing you can do, I would say shorts were expecting it to rise, but they want to control the percentage on the market. The only way to do that is to insure price going into news release is low. So whatever rise they have a plan to bring it back down for more profits. The one thing that could beat them, is if retail comes in big time for a piece of the action, might cause a real short squeeze, it's not likely, but it is possible.
What was the bad news yesterday, they manipulated by dumping stock into a short position, but I did not see or hear anything negative about the company or product of Alcobra. If you were scared off, you may have followed the leader dump. I did not, still long and a little less strong, down some dollars. STILL .. Looking for a big comeback on the 3rd or 5th after FDA review. If their was bad news leaked, the board would be closed and the stock price at $2-4.00. You know shorts are not looking for successful companies, they are just looking for a buck, a million, or a billion. Don't let them suck you in, remember you may be down but your never out until you have sold. Their are not many shares of ADHD, so whatever trades their are usually huge swings. Stay cool don't panic and watch for some great news soon.
The more that know the more reporting that will be done, eventually something will happen that will make brokerage houses report it or suffer severe consequences.
Just last month the CME announced its new Rule 575. Effective September 15, it essentially says:
DISRUPTIVE PRACTICES - It shall be unlawful for any person to engage in any trading, practice, or conduct on or subject to the rules of a registered entity that -
(A) violates bids or offers; (B) demonstrates intentional or reckless disregard for the orderly execution of transactions during the closing period; or (C) is of the character of, or is commonly known to the trade as, "spoofing" (bidding or offering with the intent to cancel the bid or offer before execution).
Wow. In sifting through the detail of the new rules, here's what especially stood out in its explanations:
Once the smaller orders are filled, the market participant cancels the large orders that had been designed to create the false appearance of market activity. Placing a bona fide order on one side of the market while entering order(s) on the other side of the market without intention to trade those orders violates Rule 575.
A market participant places a large quantity of orders at the beginning of the pre-opening period in an effort to artificially increase or decrease the IOP with the intent to attract other market participants...
It gets more specific from there.
So there you have it. The CME itself detailing exactly the type of market manipulation that they know has gone on, and now specifically outlaw.
Let's hope for pre-continuation and a strong opening.
This is not the end, it's the beginning. Just need to understand three tests are underway Fragile X Pediatric ADHD and Adult ADHD. I'm ore of a believer one or more of these will be successful. No reason not too. Stock manipulation goes on with most all Bios and is a direct result of Hedge shorting. They bet every new issue is a failure and if it is not they like to inflict pain on long investors who are usually in it for more than just a fast buck. Sooner or later the rules for them will be adjusted and their greed made more difficult. Here is wahr we got going on .. Keep the Faith ... The FDA granted "Orphan Drug" designation to Metadoxine in the treatment of Fragile X Syndrome in December 2013.
The Phase IIb Fragile X trial is a multi-center, randomized, placebo-controlled study and is being conducted in 11 clinical sites, primarily in the U.S. It is designed to investigate MDX for 6 weeks compared with placebo in 60 adolescent and adult subjects with Fragile X Syndrome.
"We expect that this study will give us important insights into the efficacy and safety of MDX in Fragile X Syndrome," said Elizabeth Berry Kravis, MD, PhD, Associate Professor of Biochemistry, Neurological Sciences, and Pediatrics at Rush University Medical Center, and the Principal Investigator of the Phase IIb study. "Fragile X Syndrome is a genetic condition that causes intellectual disability, and is the leading known genetic cause of autism. There are no approved treatments for Fragile X Syndrome, so the development of MDX in this indication has the potential to address a significant unmet need."
The trial is expected to complete enrollment and report topline data by the end of 2014.
Also, The Phase IIb trial is a multi-center, randomized, double-blind, fixed dose study designed to evaluate the safety and tolerability of MDX in up to 82 adolescents (aged 13-17) with predominantly inattentive ADHD (PI-ADHD). The primary endpoint will be safety, tolerability and pharmacokinetics. Secondary endpoints include change in efficacy measures such as TOVA (Test of Variables of Attention), Wechsler Intelligence Scale for Children (WISC-IV) subtests, and working memory and processing speed. ClinicalTrials.gov Identifier: NCT02189772
The trial is expected to complete enrollment and report topline data by the end of 2014
derrick .... So if you are out, #$%$ are you writing your irritating statements all over this board for? Who are you trying to convince and of what, or what is your point as someone else asked earlier? We all take responsibility for our own positions win or lose, but we don't scream hurrah when winning or cry about it when losing. Grin and bear it or just leave without commentary.
Bird .. The market is hardly controlled by investors, it's controlled by naked shorts, hedge funds and brokerage houses. What I don't understand is why you need to tell this board how worried you are and give it your odds. If worried, than you should sell for lack of confidence and save your money. This is Vegas the way the market is today, product matters not, Hedge funds would kill a potential and helpful product shorting it for a buck. If you don't like gambling than you need to leave. Good news will not even guarantee a good price. Most every Bio that had success with product this past year has been shorted tot he point no individual longs really want to invest, their is no money in it even for the long term, if hedge shorts stay in it. The SEC and the Justice Department have to clean this up, or individuals will get wiped out and/or leave forever. Of course the problem is every Congressman has a hedge fund investment and they are making money so their is no need for them to legislate anything for the little investor. If I were you and I was as scared as you seem to be I would pull out.
September 27 Washington Post article under business. northwest-biotherapeutics-stock-woes-highlight-the-harm-of-short-sales ... Finally exposed in mainstream media. You can find the full story.